IL-15Rα+ve TAMs lowered CX3CL1 protein levels in tumor cells, inhibiting CD8+ve T cell recruitment via secretion of the IL-15/IL-15Rα complex (IL-15Rc). This evidence concerns the gene CD8A and neoplasm.